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Abstract
Introduction
Stronger alcohol policies predict decreased alcohol consumption
and binge drinking in the United States. We examined the relation-
ship between the strength of states’ alcohol policies and alcoholic
cirrhosis mortality rates.
Methods
We used the Alcohol Policy Scale (APS), a validated assessment
of policies of the 50 US states and Washington DC, to quantify the
efficacy and implementation of 29 policies. State APS scores (the-
oretical range, 0–100) for each year from 1999 through 2008 were
compared with age-adjusted alcoholic cirrhosis death rates that oc-
curred 3 years later. We used Poisson regression accounting for
state-level clustering and adjusting for race/ethnicity, college edu-
cation, insurance status, household income, religiosity, policing
rates, and urbanization.
Results
Age-adjusted alcoholic cirrhosis mortality rates varied signific-
antly across states; they were highest among males, among resid-
ents in states in the West census region, and in states with a high
proportion of American Indians/Alaska Natives (AI/ANs). Higher
APS scores were associated with lower mortality rates among fe-
males (adjusted incidence rate ratio [IRR], 0.91 per 10-point in-
crease  in  APS  score;  95%  confidence  interval  [95%  CI],
0.84–0.99) but not among males (adjusted IRR, 0.97; 95% CI,
0.90–1.04).  Among non-AI/AN decedents,  higher  APS scores
were also associated with lower alcoholic cirrhosis mortality rates
among  both  sexes  combined  (adjusted  IRR,  0.89;  95%  CI,
0.82–0.97). Policies were more strongly associated with lower
mortality  rates  among those  living in  the  Northeast  and West
census regions than in other regions.
Conclusions
Stronger alcohol policy environments are associated with lower al-
coholic cirrhosis mortality rates. Future studies should identify un-
derlying reasons for racial/ethnic and regional differences in this
relationship.
Introduction
Excessive alcohol consumption is the third leading preventable
cause of death in the United States; alcoholic cirrhosis accounts
for nearly half of all cirrhosis deaths (1,2). Although the age-ad-
justed alcoholic cirrhosis mortality rate in the United States is
lower than the global average (3.3 compared with 5.9 deaths per
100,000 per year), it has steadily and significantly increased dur-
ing the past decade (1). Moreover, significant differences exist
among demographic subgroups; death rates are particularly high
among American Indians/Alaska Natives (AI/ANs) (3).
Stronger  state-level  alcohol  policies  have  been  linked  to  de-
creased binge drinking (4,5). State alcohol policies include di-
verse interventions such as implementing alcohol excise taxes;
regulating the location, time, and quantity of alcohol sales; and re-
stricting retail signage and media advertising (6,7). To date, most
studies of alcohol-related outcomes have examined single policy
changes (8–11). However, alcohol consumption is simultaneously
affected by multiple policies of varying efficacy and levels of im-
plementation. Therefore, it is critical to consider states’ overall al-
cohol policy environments. Furthermore, analyses should care-
fully examine subpopulations, including AI/ANs, who have high
alcohol-related mortality rates and may live in autonomous re-
gions where policies may have poor penetration (3,12).
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Understanding alcohol  policy  environments  and their  links  to
health may inform policy makers who seek to reduce alcohol-re-
lated harm. To examine the association between policies and alco-
holic cirrhosis mortality rates, we used the Alcohol Policy Scale
(APS) score, which quantifies states’ alcohol policy environments
by considering not only the efficacy of policies but also their de-
gree of implementation (4). We hypothesized that stronger policy
environments would be associated with lower alcoholic cirrhosis
mortality rates but that this association might not be as robust for
AI/ANs.
Methods
The Alcohol Policy Scale (APS) is a validated assessment of alco-
hol policies of the 50 US states and Washington, DC, that was de-
scribed previously (4,6). Briefly, the APS integrated ratings on the
efficacy and degree of implementation of 29 policies collected and
assessed by a Delphi panel. Panel members were experts from aca-
demia, government, and the private sector and represented a range
of disciplines,  including law, epidemiology, psychology, soci-
ology, and economics.
Each  panelist  independently  nominated  alcohol  policies  con-
sidered to effectively reduce excessive drinking or alcohol-related
harm. The primary source for policies was the Alcohol Policy In-
formation System maintained by the National Institute on Alcohol
Abuse and Alcoholism (13). Examples of policies incorporated in-
to a state’s APS score included alcohol taxes, retail price restric-
tions, and hours of sales regulations; a full list is available else-
where (6). The APS incorporated information on the efficacy and
legislative implementation of each alcohol policy.
To determine the efficacy of each policy, the study investigators
generated idealized descriptions for each policy. For each state-
year, panelists independently rated the efficacy of each policy for
reducing binge drinking in the general population on the basis of
their expertise and available scientific evidence. Ratings were on a
5-point Likert scale (1 = low efficacy to 5 = high efficacy) and
provided for each state and year. (A separate ratings process ex-
amined policy efficacy for reducing binge drinking among youths
and alcohol-impaired driving, but these efficacy ratings were not
considered in these analyses.) Next, panelists met to review the
combined ratings and discuss their individual ratings, focusing on
the strength of the scientific literature supporting each policy. Af-
terward, each panelist  again independently rated each policy a
second time concerning reducing binge drinking in the general
population. These final ratings comprised the efficacy component
of the APS.
To determine the implementation of each alcohol policy, study in-
vestigators generated an implementation rating scale on the basis
of the statutory design of each policy, specifically considering pro-
visions that made the policy broadly applicable, effective, or en-
forceable (4). Panelists then provided feedback on the implement-
ation rating scales, which were subsequently revised by the study
investigators. Then the scales were applied to all policies for each
state and year, with a range of 0 (no policy) to 1.0 (policy with full
implementation).
Ultimately, 29 policies were included in the APS. To generate an
overall APS score for each state and year, each efficacy score was
multiplied by its implementation score and summed with all other
policies for that state and year (4,6). Scores were standardized
such that the theoretical range of the APS score was from 0 to 100;
high APS scores represented strong alcohol policy environments.
APS scores from 1999 through 2008 were used in these analyses.
Age-adjusted alcoholic cirrhosis mortality rates were obtained
from the Centers for Disease Control and Prevention (CDC) Wide-
Ranging Online Data for Epidemiologic Research (WONDER)
system. Using the International Classification of Diseases, 10th
Revision, Clinical Modification code K70.x (alcoholic liver dis-
ease), we extracted age-adjusted mortality data for all 50 states
and Washington, DC, for all years from 2002 through 2011, and
for males and females separately, resulting in 1,020 observations
(14). The range 2002 through 2011 was selected to allow for a 3-
year lag between APS score and associated mortality rates. Of the
1,020 state-year observations, 123 (12.1%) were suppressed by the
CDC WONDER system because of insufficient counts for that
state-year to preserve confidentiality. In such cases, a 2-year run-
ning average was used, such that the overall mortality rate in a
state for a suppressed year was combined with the rate from the
previous year, which usually provided sufficient counts so that the
rate was no longer suppressed. By this process, 105 (10.3%) miss-
ing mortality rates were imputed, leaving only 18 (1.8%) state-
year observations suppressed.
We examined age-adjusted rates for 2010–2011, the most recent
years analyzed, and generated a map comparing APS scores and
age-adjusted alcoholic  cirrhosis  mortality  rates  for  both sexes
combined to examine geographical differences. Because regional
differences in mortality rates were apparent after constructing this
map, we examined age-adjusted mortality rates by sex according
to US census region (region 1 [Northeast], region 2 [Midwest], re-
gion 3 [South], region 4 [West]). Because we hypothesized that
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the association between APS and mortality rate might be modi-
fied by race/ethnicity, we also examined mortality rates by sex ac-
cording to states’ proportion of racial/ethnic subgroups (non-His-
panic white, non-Hispanic black, Hispanic, and AI/AN [including
Hispanic AI/AN]).
We then examined the association between APS and mortality
rates. Each state-year of mortality data was matched to the corres-
ponding APS using a 3-year lag. For example, states’ APS scores
from 1999 were related to mortality rates for 2002. The 3-year lag
was used to increase the number of overlapping years of  APS
scores  and mortality  data  (compared with a  longer  lag,  which
would have resulted in fewer overlapping years of  data).  This
shorter lag period was consistent with evidence showing that alco-
hol policy changes may demonstrate an early effect on cirrhosis
death rates (15–17).
Analyses used Poisson regression with robust standard error es-
timates to account for state-level clustering (18). Incidence rate ra-
tios (IRRs) were adjusted for state-level race/ethnicity, college
education, insurance status, household income, religiosity, poli-
cing rates, level of urbanization, and study year as an indicator
variable. Covariates were extracted from the US Census Bureau’s
American Community Survey and Current Population Survey and
were time-updated to match the mortality rate for each state-year
observation (19–21). As a sensitivity analysis, we also repeated all
models using a fixed effects approach in which we included an in-
dicator variable for every state and repeated all models using a
random intercepts approach in which state was a level 2 variable;
results were consistent with the findings from the robust sandwich
standard error estimates (not shown).
To examine regional differences in the association between APS
and alcoholic cirrhosis mortality rates, we also conducted ana-
lyses  stratified by census region.  Recognizing that  AI/ANs in
many places in the United States have elevated alcohol-related
mortality rates (3) and that state health policies may not penetrate
sovereign or physically remote AI/AN locales (12), we also strati-
fied  analyses  according  to  states  with  proportion  of  AI/ANs
(≥2.5% or  <2.5%).  Proportions  were  time-updated  during  the
study period. We also repeated analyses using mortality data ex-
tracted from CDC WONDER that excluded AI/AN decedents. Fi-
nally, we generated scatterplots of states’ proportion of AI/ANs
and alcoholic cirrhosis mortality rates according to sex, using the
most recent years of data examined (2010–2011).
Analyses were performed using STATA version 13/SE (Stata-
Corp LP). All P values were 2-sided, and tests were considered
significant at P < .05.
Results
For all states from 1999 through 2008, the mean APS score was 41
(range, 23–66) and increased during the study period (mean APS
in 1999, 38; mean APS in 2008, 42; P < .001). The mean age-ad-
justed alcoholic cirrhosis mortality rate for the United States from
2002 through 2011 was 4.7 deaths per 100,000 per year (95% con-
fidence interval [CI], 4.2–5.3) with a range of 2.5 (Pennsylvania)
to  10.3  (New Mexico).  Alcoholic  cirrhosis  mortality  rates  in-
creased during the study period (mean age-adjusted mortality rate
in 2002 was 4.6 deaths per 100,000; mean rate in 2011 was 5.3
deaths per 100,000; P < .001).
During the 2 most recent years studied (2010–2011), age-adjusted
alcoholic cirrhosis mortality rates for males were significantly
higher than those for females, and there was substantial variability
between states (Table 1). Figure 1 shows states’ mortality rates
and APS score tertiles for both sexes combined. In general, there
was considerable geographic variation in alcoholic cirrhosis mor-
tality rates; rates among states in the West census region were
higher than among those in other US census regions.
Figure 1.  State age-adjusted alcoholic  cirrhosis  mortality  rates (men and
women combined) and associated alcohol policy score tertiles. Mortality rates
from 2010–2011 were compared with alcohol policy scores from 2008 to
introduce a 2- to 3-year lag. States with the highest tertile of alcohol policy
score (ie, strongest policy environment) are marked by 3 asterisks (***); the
middle tertile, by 2 asterisks (**); and the lowest tertile, by a single asterisk
(*).
 
Mean age-adjusted alcoholic cirrhosis mortality rates during the
entire study period (2002–2011) were analyzed according to ra-
cial/ethnic group and census region (Table 2). In every comparis-
on, mortality rates were significantly higher among males than
among females. Significant differences in mortality rates were
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noted between females from states with differing proportion of
non-Hispanic blacks (≥5% and <5%) and between states with dif-
fering proportions of AI/ANs (≥2.5% and <2.5%) for both sexes.
Region 4 (West) had significantly higher mortality rates than oth-
er regions for both sexes.
In unadjusted analyses, APS score was not significantly associ-
ated with alcoholic cirrhosis mortality when both sexes were con-
sidered together (IRR, 0.93 per 10-point increase in APS score;
95% CI,  0.80–1.07)  and separately  (male  IRR,  0.95;  95% CI,
0.83–1.08; female IRR, 0.86; 95% CI, 0.72–1.04). After adjusting
for covariates, higher APS score was significantly associated with
lower alcoholic cirrhosis mortality rates among females but not
among males, and among the overall population when both sexes
were combined (Table 3).
Additionally, significant geographical variation was seen in the as-
sociation between APS score and alcoholic cirrhosis mortality
rates. For both sexes, APS score was significantly associated with
decreased mortality rates in the Northeast and South census re-
gions, but not in the Midwest or West regions. Furthermore, the
association of APS score with lower mortality rates was present in
states with less than 2.5% of AI/ANs but not in states with 2.5% or
more AI/ANs. When analyses were repeated excluding all AI/AN
decedents, geographical variation was again present in the associ-
ation between APS score and alcoholic cirrhosis mortality rates.
For both sexes combined, APS score was significantly associated
with decreased mortality rates in the Northeast and West, a find-
ing that also held when males were analyzed separately; when fe-
males were analyzed separately, the association was significant
only in the Northeast.
Scatterplots  of  state age-adjusted alcoholic cirrhosis  mortality
rates by the proportion of AI/ANs are depicted in Figure 2. In gen-
eral, as the proportion of AI/ANs increased, mortality rates in-
creased.
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Figure 2. Relationship between proportion of American Indians/Alaska Natives
in states’ populations and age-adjusted alcoholic cirrhosis mortality rates of
states among (2a) both sexes [r2 = 0.320, P < .001], (2b) males [r2 = 0.473,
P  <  .001],  and  (2c)  females  [r2  =  0.217,  P  =  .001],  United  States,
2010–2011. Solid line represents curve of best fit determined by the least-
squares method. Hashed lines represent upper and lower 95% confidence
intervals.
 
Discussion
We found that stronger state alcohol policy environments were as-
sociated with lower alcoholic cirrhosis mortality rates for certain
regions and racial/ethnic groups in the United States. Using the
APS score, which quantifies a state’s alcohol policy environment,
we found that a 10-point increase (ie, a stronger policy environ-
ment) was associated with a 9% decrease in alcoholic cirrhosis
mortality among females. To provide context to this 10-point dif-
ference, the range of APS scores observed across states during the
study period was 23 to 66, so there is notable between-state vari-
ation in the strength of alcohol policy environments. Examining
mortality rates among non-AI/AN decedents indicated that a 10-
point increase in APS score was associated with an 11% decrease
in mortality among both sexes, a finding driven primarily by fe-
males, whose mortality rate decreased by 18% for a 10-point in-
crease in APS score.
These findings are consistent with the recent finding that stronger
state alcohol policy environments in the United States are associ-
ated with decreased binge drinking prevalence (4). Coupled with
data suggesting that alcohol consumption is tied to alcoholic cir-
rhosis mortality at the aggregate level (7,15,22), our results are
consistent with a potentially protective role for alcohol policies in
reducing cirrhosis mortality. State alcohol policies aimed at redu-
cing  alcohol  consumption  in  the  general  population  are  more
strongly associated with reduced binge drinking than are more tar-
geted policies, such as policies focusing solely on underage drink-
ing or impaired driving (5). Tax and price policies appear to be
particularly effective for reducing adult binge drinking as well as
alcoholic cirrhosis mortality rates and are likely critical compon-
ents of a robust alcohol policy environment (5,7,11,23,24).
Although alcoholic cirrhosis mortality has a long lag period, last-
ing up to decades of alcohol exposure (25), our findings showed a
significant association between alcohol policy environments and
mortality rates using only a 3-year lag. At the aggregate level,
however, there may be an immediate effect on cirrhosis mortality
demonstrated  after  sudden  declines  in  alcohol  consumption
(7,15,17,25). As suggested previously (7,17), at any given time,
there exists a reservoir of individuals with a prior and extensive
history of drinking and alcoholic cirrhosis who are approaching a
mortality threshold. If per capita alcohol consumption increases, a
large number of those individuals are at greater risk of death in the
near future; if per capita alcohol consumption decreases, those
same individuals are at lower risk of immediate mortality. This
phenomenon was observed historically after the institution and
subsequent repeal of prohibition in the United States (15). Our res-
ults support that strengthening alcohol policy environments may
be beneficial for the overall population in the short-term, despite
the long lag between alcohol consumption and death from cir-
rhosis observed at the individual level.
The association of strong alcohol policy environments with mor-
tality rate in the overall population was driven primarily by the
death rate among females. Alcohol policy environments may have
a greater effect on excess alcohol consumption among females
than among males (5,26). We also noted that alcohol policy envir-
onments were not as strongly associated with reduced alcoholic
cirrhosis mortality rates when AI/AN decedents were included in
analyses. Our findings are consistent with evidence demonstrating
elevated rates of alcohol-related death among AI/AN populations
relative to other US populations (3) and suggest that changes in al-
cohol policies may be less protective for AI/AN individuals who
live in autonomous or physically remote regions in which state al-
cohol policies have poor penetration (12). Additionally, our study
did not  examine the  potential  protective  role  of  tribal  alcohol
policies, an area that requires further study (27,28).
Finally, we noted significant regional variation in the relationship
between alcohol policy environment and mortality rates, with the
strongest association noted in the Northeast census region. Other
studies have shown significant regional variation in the effects of
alcohol policy on drinking-related behaviors (4,9,10,15,26,29), in-
cluding a recent assessment of alcohol poisoning deaths in the
United States that showed high mortality in the West census re-
gion relative to the Northeast and South (30). It is possible that en-
forcement of alcohol policies may vary across regions and contrib-
ute to the differences in effect sizes observed in our study or that
proximity to care varies among states. Future studies should con-
tinue to assess the differential effects of alcohol policies on other
health concerns that are linked to excessive alcohol use for specif-
ic population subgroups according to sex, race/ethnicity, and geo-
graphical location.
This  study has  several  limitations.  Although we carefully  ex-
amined the efficacy and implementation of alcohol policies, the
APS score does not incorporate enforcement of policies given the
absence of any reliable publicly available data on enforcement
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across states. Nonetheless, when designing the APS score, study
investigators and the expert panel incorporated into the imple-
mentation ratings policy provisions that made policies more likely
to be enforceable (4,6). Our analyses also controlled for number of
police officers per capita as a state-level covariate to help account
for variations in enforcement.
Additionally, despite using a lag period between exposure and out-
come and controlling for year, there remains the possibility of re-
verse causation between APS score and alcoholic cirrhosis mortal-
ity. Specifically, states that had lower consumption of alcohol may
have been the same states that implemented strong alcohol policy
environments. We introduced a 3-year lag between a state’s APS
score and associated mortality rate to allow time for state policies
to be implemented and enforced; this lag helps to establish tem-
porality, even if causation cannot be fully established. We also
cannot  exclude residual  confounding despite  controlling for  a
range of state-level covariates. We exclusively studied alcoholic
cirrhosis and did not examine the contribution of other potentially
overlapping causes of cirrhosis, such as hepatitis C. Finally, al-
though the APS incorporates state-level alcohol policies, it does
not include federal or local policies (eg, federal regulations on al-
cohol marketing, county or municipal taxes on alcohol purchases,
tribal alcohol policies).
This  study established an  association  between the  strength  of
states’ alcohol policy environments and mortality from a leading
alcohol-attributable cause of death. Future studies should further
assess the strength and directionality of this association. Our find-
ings suggest that strengthening alcohol policy environments may
be an effective intervention for reducing cirrhosis mortality. Re-
searchers and policy makers should additionally consider whether
alcohol policies are uniformly protective for all citizens, given that
significant disparities in mortality rates persist for AI/ANs relat-
ive to others.
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Tables
Table 1. Age-Adjusted Alcoholic Cirrhosis Mortality Ratesa Per 100,000 Population Per Year, by State, United States,
2010–2011
State
Overall Males Females
Rate (95% Confidence Interval)
US average 4.8 (4.7–4.8) 7.0 (6.9–7.1) 2.7 (2.6–2.8)
New Mexico 11.5 (10.5–12.6) 16.4 (14.6–18.1) 7.1 (5.9–8.2)
Arizona 9.3 (8.7–9.8) 13.1 (12.3–14.0) 5.8 (5.2–6.3)
Wyoming 8.7 (7.0–10.5) 10.8 (8.2–13.8) 6.7 (4.7–9.3)
Oregon 8.5 (7.9–9.2) 11.7 (10.7–12.7) 5.6 (4.9–6.3)
California 8.2 (8.0–8.5) 12.3 (11.9–12.6) 4.6 (4.4–4.8)
Washington 8.2 (7.7–8.7) 11.0 (10.2–11.8) 5.6 (5.0–6.1)
South Dakota 8.1 (6.7–9.5) 10.3 (8.2–12.8) 6.1 (4.5–8.1)
North Dakota 7.8 (6.3–9.3) 10.4 (8.1–13.1) 5.2 (3.6–7.4)
Montana 7.7 (6.5–8.9) 10.3 (8.4–12.2) 5.2 (3.9–6.8)
Colorado 7.5 (7.0–8.1) 10.5 (9.6–11.4) 4.8 (4.2–5.4)
Oklahoma 7.5 (6.9–8.1) 10.3 (9.3–11.3) 4.9 (4.2–5.6)
Alaska 7.4 (6.0–8.9) 8.0 (6.1–10.3) 6.8 (5.0–8.9)
Idaho 7.2 (6.3–8.1) 8.8 (7.3–10.3) 5.7 (4.6–7.0)
Nevada 6.6 (5.9–7.2) 8.3 (7.2–9.3) 4.8 (4.0–5.7)
Vermont 5.5 (4.4–6.8) 7.7 (5.8–10.0) 3.4 (2.2–5.0)
Florida 5.1 (4.9–5.3) 7.5 (7.1–7.9) 3.0 (2.8–3.2)
Nebraska 5.1 (4.4–5.8) 6.7 (5.6–7.9) 3.7 (2.8–4.6)
Rhode Island 4.9 (4.0–5.7) 7.6 (6.1–9.3) 2.5 (1.7–3.5)
Michigan 4.8 (4.5–5.1) 6.9 (6.4–7.4) 2.9 (2.6–3.2)
District of Columbia 4.7 (3.5–6.1) 6.1 (4.2–8.5) 3.4 (2.1–5.2)
South Carolina 4.6 (4.2–5.0) 7.3 (6.5–8.0) 2.3 (1.9–2.7)
Tennessee 4.6 (4.3–5.0) 7.0 (6.4–7.7) 2.4 (2.0–2.7)
Maine 4.5 (3.8–5.2) 6.3 (5.1–7.6) 2.9 (2.2–3.8)
Wisconsin 4.5 (4.1–4.9) 6.3 (5.6–6.9) 2.8 (2.3–3.2)
Iowa 4.4 (3.9–4.9) 6.4 (5.5–7.3) 2.5 (2.0–3.1)
Texas 4.3 (4.2–4.5) 6.7 (6.4–7.1) 2.1 (1.9–2.3)
New Hampshire 4.2 (3.5–4.9) 6.3 (5.1–7.6) 2.4 (1.7–3.3)
West Virginia 4.2 (3.5–4.8) 6.5 (5.4–7.6) 1.9 (1.4–2.6)
Minnesota 4.1 (3.7–4.5) 5.5 (4.9–6.1) 2.8 (2.3–3.2)
Abbreviations: CDC, Centers for Disease Control and Prevention; NA, not applicable; WONDER, Wide-Ranging Online Data for Epidemiologic Research.
a All age-adjusted rates obtained from CDC WONDER database and are averaged for 2010–2011.
b Mortality data for females in Delaware were not available due to insufficient counts in CDC WONDER database.
(continued on next page)
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(continued)
Table 1. Age-Adjusted Alcoholic Cirrhosis Mortality Ratesa Per 100,000 Population Per Year, by State, United States,
2010–2011
State
Overall Males Females
Rate (95% Confidence Interval)
Ohio 4.1 (3.8–4.3) 6.1 (5.7–6.6) 2.2 (1.9–2.4)
Kansas 4.0 (3.5–4.5) 6.1 (5.2–7.0) 2.0 (1.6–2.6)
Hawaii 4.0 (3.3–4.7) 6.0 (4.8–7.4) 2.1 (1.4–2.9)
North Carolina 4.0 (3.7–4.2) 6.2 (5.7–6.7) 2.0 (1.7–2.3)
Indiana 3.9 (3.6–4.2) 6.0 (5.4–6.5) 2.0 (1.7–2.3)
New York 3.4 (3.2–3.6) 5.3 (4.9–5.6) 1.7 (1.6–1.9)
Utah 3.4 (2.8–3.9) 4.5 (3.6–5.4) 2.3 (1.8–3.0)
Kentucky 3.2 (2.8–3.7) 4.8 (4.0–5.6) 1.7 (1.3–2.3)
Arkansas 3.2 (2.9–3.6) 5.3 (4.6–6.0) 1.4 (1.0–1.7)
Missouri 3.2 (2.9–3.5) 4.7 (4.2–5.3) 1.7 (1.4–2.0)
Illinois 3.1 (2.9–3.4) 4.5 (4.2–4.9) 1.9 (1.6–2.1)
Mississippi 3.0 (2.6–3.4) 5.0 (4.2–5.8) 1.2 (0.9–1.7)
New Jersey 2.9 (2.7–3.2) 4.4 (3.9–4.8) 1.7 (1.4–1.9)
Georgia 2.9 (2.7–3.2) 4.6 (4.2–5.0) 1.4 (1.2–1.6)
Massachusetts 2.9 (2.6–3.2) 4.4 (3.9–4.9) 1.5 (1.2–1.8)
Alabama 2.9 (2.5–3.2) 4.6 (4.0–5.2) 1.4 (1.1–1.7)
Delaware 2.8 (2.1–3.6) 4.7 (3.4–6.2) NAb
Pennsylvania 2.8 (2.6–3.0) 4.0 (3.7–4.4) 1.6 (1.4–1.8)
Virginia 2.7 (2.4–2.9) 3.9 (3.5–4.3) 1.6 (1.4–1.9)
Connecticut 2.7 (2.3–3.0) 3.9 (3.3–4.6) 1.6 (1.2–2.0)
Louisiana 2.7 (2.3–3.0) 4.0 (3.4–4.6) 1.5 (1.1–1.8)
Maryland 2.5 (2.2–2.8) 3.7 (3.2–4.2) 1.4 (1.2–1.7)
Abbreviations: CDC, Centers for Disease Control and Prevention; NA, not applicable; WONDER, Wide-Ranging Online Data for Epidemiologic Research.
a All age-adjusted rates obtained from CDC WONDER database and are averaged for 2010–2011.
b Mortality data for females in Delaware were not available due to insufficient counts in CDC WONDER database.
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Table 2. Mean Age-Adjusted Alcoholic Cirrhosis Mortality Rates Per 100,000 Population Per Year, by Mean State-Level
Characteristic, United States, 2002–2011
State Characteristic
Mortality Per 100,000 Per Year (95% CI)
Overall Males Females
All races/ethnicities and regions 4.5 (3.5–5.5) 6.7 (5.2–8.2) 2.4 (1.9–2.9)
% Non-Hispanic white
<80 4.8 (3.4–6.3) 7.2 (5.1–9.4) 2.5 (1.7–3.3)
≥80 4.0 (3.4–4.6) 5.8 (5.1–6.6) 2.2 (1.8–2.6)
% Non-Hispanic black
<5 5.9 (4.8–6.9) 8.3 (6.7–9.9) 3.5 (2.8–4.1)
≥5 4.1 (3.1–5.1) 6.1 (4.6–7.7) 2.0 (1.5–2.6)
% Hispanic
<5 3.9 (3.3–4.4) 5.8 (5.0–6.7) 2.0 (1.7–2.3)
≥5 5.6 (4.1–7.0) 8.1 (6.0–10.3) 3.0 (2.3–3.8)
% American Indian/Alaska Native
<2.5 4.2 (3.1–5.3) 6.3 (4.7–8.0) 2.2 (1.6–2.8)
≥2.5 7.4 (6.7–8.0) 10.2 (9.3–11.1) 4.5 (4.1–5.0)
Census region
1 (Northeast) 3.0 (2.7–3.3) 4.5 (4.0–5.0) 1.5 (1.4–1.7)
2 (Midwest) 3.7 (3.3–4.1) 5.4 (4.8–6.0) 2.0 (1.8–2.3)
3 (South) 3.8 (3.3–4.4) 5.9 (5.1–6.6) 1.9 (1.5–2.2)
4 (West) 7.6 (6.9–8.3) 10.9 (9.5–12.3) 4.2 (4.0–4.5)
Abbreviation: CI, confidence interval.
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Table 3. Incidence Rate Ratios (IRRs) for Association of Alcohol Policy Scale (APS) Scorea With State-Level, Age-Adjusted
Alcoholic Cirrhosis Mortality Rates, by US Census Region and by State Proportion of American Indians/Alaska Natives (AI/
ANs), 2002–2011
Subcategory
Adjusted IRR (95% Confidence Interval)b
Overall Males Females
All races/ethnicitiesc 0.95 (0.88–1.03) 0.97 (0.90–1.04) 0.91 (0.84–0.99)
Census regiond
1 (Northeast) 0.68 (0.60–0.78) 0.70 (0.60–0.82) 0.61 (0.58–0.65)
2 (Midwest) 1.01 (0.93–1.09) 1.02 (0.96–1.09) 0.96 (0.81–1.14)
3 (South) 0.87 (0.76–0.99) 0.87 (0.77–0.98) 0.82 (0.71–0.95)
4 (West) 0.87 (0.73–1.03) 0.89 (0.75–1.05) 0.83 (0.68–1.00)
AI/ANd,e, %
<2.5 0.90 (0.82–0.98) 0.90 (0.82–0.98) 0.88 (0.81–0.96)
≥2.5 0.98 (0.89–1.08) 0.99 (0.90–1.08) 0.98 (0.86–1.11)
All races/ethnicities, excluding AI/AN decedentsc 0.89 (0.82–0.97) 0.94 (0.87–1.01) 0.82 (0.69–0.98)
Census region
1 (Northeast) 0.55 (0.43–0.72) 0.71 (0.60–0.84) 0.39 (0.25–0.61)
2 (Midwest) 0.99 (0.92–1.07) 1.01 (0.95–1.08) 0.95 (0.80–1.12)
3 (South) 0.79 (0.59–1.06) 0.91 (0.78–1.06) 0.59 (0.35–1.01)
4 (West) 0.89 (0.80–0.99) 0.83 (0.70–0.99)       0.96 (0.85–1.09)
a A 3-year lag was introduced between APS score and mortality rates (eg, states’ mortality rates from 2002 were associated with APS scores from
1999).
b IRR reported per 10-point increase in APS score; models adjusted for year, race/ethnicity, college education, insurance status, household income, re-
ligiosity, policing rates, and proportion living in rural/urban areas.
c IRR is adjusted for all covariates as well as census region and proportion of AI/ANs.
d Model stratified by census region is adjusted for all covariates, as well as proportion of AI/ANs; model stratified by proportion of AI/ANs is adjusted for
all covariates, as well as census region.
e Includes 806 state-year observations with the proportion of AI/ANs <2.5% and 214 observations with proportion ≥2.5%.
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